1-3 of 3
Samantha A Dagger
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The FLT3 Inhibitor Quizartinib Provides a Novel Strategy to Inhibit Chemotherapy-Induced Myelosuppression

Wallace Y Langdon, PhD, Samuel J Taylor, PhD, Johanna M Duyvestyn, BSc(Hons), Samantha A Dagger, BSc(Hons), George S. Vassiliou, MD PhD, Carolyn s. Grove, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4041.
https://doi.org/10.1182/blood.V128.22.4041.4041
Published: 2016
Journal Articles

Flt3 inhibitor AC220 is a potent therapy in a mouse model of myeloproliferative disease driven by enhanced wild-type Flt3 signaling

Samuel J. Taylor, Samantha A. Dagger, Christine B. F. Thien, Matthew E. Wikstrom, Wallace Y. Langdon
Journal: Blood
Blood (2012) 120 (19): 4049–4057.
https://doi.org/10.1182/blood-2012-06-436675
Published: 2012
Includes: Supplemental data
Journal Articles

FLT3 Inhibitor AC220 Is a Potent Therapy for Myeloproliferative Disease in c-Cbl RING Finger Mutant Mice

Wallace Y Langdon, PhD, Samantha A Dagger, Samuel J Taylor, Christine B F Thien, PhD, Matthew E Wikstrom, PhD
Journal: Blood
Blood (2011) 118 (21): 642.
https://doi.org/10.1182/blood.V118.21.642.642
Published: 2011